Drug Treatment and Cost of Cardiovascular Disease in Australia-Reference-Cited by-同舟云学术

Drug Treatment and Cost of Cardiovascular Disease in Australia

Published:2009-09 Issue:3 Volume:27 Page:164-172
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:

Author:

Ademi Zanfina,Liew Danny,Chew Derek,Conner Greg,Shiel Louise,Nelson Mark,Soman Ash,Steg Gabriel,Bhatt Deepak L.,Reid Christopher,

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2009.00090.x/fullpdf

Reference45 articles.

1. 1. Pharmaceutical Benefits Schedule Item Reports. Period September 2006 to September 2007. Available from: https://www.medicareaustralia.gov.au/statistics/pbs_item.shtml.

2. Costs and medical care consequences associated with the diagnosis of peripheral arterial disease;Migliaccio-Walle;Pharmacoeconomics,2005

3. Cost of atherothrombotic diseases-myocardial infarction, ischeamic stroke and peripherial arterial occlusive disease-in Germany;Bruggenjurgen;J Public Health,2005

4. Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences;Viles-Gonzalez;Eur Heart J,2004

5. Atherothrombosis: A major health burden;Leys;Cerebrovasc Dis,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with Pharmaceutical Benefits Advisory Committee decisions for listing medicines for diabetes and its associated complications;Australian Health Review;2022-12-22

2. One third of hospital costs for atherothrombotic disease are attributable to readmissions: a linked data analysis;BMC Health Services Research;2014-08-08

3. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data;International Journal of Cardiology;2014-07

4. The Association of Visceral Adiposity with Cardiovascular Events in Patients with Peripheral Artery Disease;PLoS ONE;2013-12-27

5. Cross vascular risk for first and recurrent hospitalised atherothrombosis determined retrospectively from linked data;BMJ Open;2013-11